In CVD, the activation of Nrf2 can protect vascular tissue from OS damage and significantly attenuate cardiac arrhythmia, cardiac hypertrophy, and myocardial fibrosis. This evidence concerns the gene NFE2L2 and cardiac hypertrophy.